These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19796545)

  • 1. The 3435T polymorphism in the ABCB1 gene and colchicine unresponsiveness in familial Mediterranean fever.
    Bezalel Y; Gershoni-Baruch R; Dagan E; Lidar M; Livneh A
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S103-4. PubMed ID: 19796545
    [No Abstract]   [Full Text] [Related]  

  • 2. About colchicine compliance, resistance and virulence.
    Ben-Chetrit E; Aamar S
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S1-3. PubMed ID: 19796522
    [No Abstract]   [Full Text] [Related]  

  • 3. Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients.
    Ozen F; Silan C; Uludag A; Candan F; Silan F; Ozdemir S; Atik S; Ozdemir O
    Ren Fail; 2011; 33(9):899-903. PubMed ID: 21851199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever.
    Tufan A; Babaoglu MO; Akdogan A; Yasar U; Calguneri M; Kalyoncu U; Karadag O; Hayran M; Ertenli AI; Bozkurt A; Kiraz S
    J Rheumatol; 2007 Jul; 34(7):1540-4. PubMed ID: 17610314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between response to colchicine treatment and MDR1 polymorphism in familial Mediterranean fever patients.
    Uludag A; Silan C; Atik S; Akurut C; Uludag A; Silan F; Ozdemir O
    Genet Test Mol Biomarkers; 2014 Feb; 18(2):73-6. PubMed ID: 24180297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous colchicine treatment for six months: adjunctive therapy in familial Mediterranean fever (FMF) unresponsive to oral colchicine.
    Rozenbaum M; Boulman N; Feld J; Avshovich N; Petrovich S; Elias M; Slobodin G; Rosner I
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S105. PubMed ID: 19796546
    [No Abstract]   [Full Text] [Related]  

  • 7. Leucopenia resoluted with colchicine in familial mediterranean Fever.
    Sakallioglu O
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):162. PubMed ID: 22031120
    [No Abstract]   [Full Text] [Related]  

  • 8. Different pharmaceutical preparations of colchicine for Familial Mediterranean Fever: are they the same?
    Emmungil H; İlgen U; Turan S; Yaman S; Küçükşahin O
    Rheumatol Int; 2020 Jan; 40(1):129-135. PubMed ID: 31463607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of polymorphisms in the colchicine binding site of tubulin in colchicine-resistant familial Mediterranean fever patients.
    Akbaba TH; Ustabas G; Kasap-Cuceloglu M; Ozen S; Balci-Peynircioglu B
    Mol Biol Rep; 2020 Nov; 47(11):9005-9011. PubMed ID: 33161498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Infliximab in colchicine resistant familial Mediterranean fever.
    Antón Vázquez V; Güell Farré E; Corominas H
    Med Clin (Barc); 2017 Dec; 149(11):510-511. PubMed ID: 28756998
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial Mediterranean Fever.
    Kucuk A; Gezer IA; Ucar R; Karahan AY
    Acta Medica (Hradec Kralove); 2014; 57(3):97-104. PubMed ID: 25649364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of amyloidosis in familial Mediterranean fever with colchicine: a case-control study in Armenia.
    Sevoyan MK; Sarkisian TF; Beglaryan AA; Shahsuvaryan GR; Armenian HK
    Med Princ Pract; 2009; 18(6):441-6. PubMed ID: 19797919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of familial Mediterranean fever with emphasis on pyrin and colchicine.
    Dbouk HA; Uthman IW
    J Med Liban; 2008; 56(1):35-41. PubMed ID: 19534089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine treatment in children with familial Mediterranean fever: is it a risk factor for neuromyopathy?
    Işıkay S; Yılmaz K; Yiğiter R; Balat A; Büyükçelik M
    Pediatr Neurol; 2013 Dec; 49(6):417-9. PubMed ID: 24084143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infantile colitis as a novel presentation of familial Mediterranean fever responding to colchicine therapy.
    Egritas O; Dalgic B
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):102-5. PubMed ID: 21694544
    [No Abstract]   [Full Text] [Related]  

  • 16. Colchicine and ocular surface changes in familial Mediterranean fever.
    Lazar M; Rothkoff L
    Acta Ophthalmol; 2010 Mar; 88(2):e5; author reply e6. PubMed ID: 19681787
    [No Abstract]   [Full Text] [Related]  

  • 17. Colchicine is a safe drug in children with familial Mediterranean fever.
    Padeh S; Gerstein M; Berkun Y
    J Pediatr; 2012 Dec; 161(6):1142-6. PubMed ID: 22738946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: acute hydrops and spontaneous corneal perforation in a patient with keratoconus treated with colchicine for familial Mediterranean fever.
    Hilely A; Kleinmann G
    Int Ophthalmol; 2019 Jun; 39(6):1367-1369. PubMed ID: 29713855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing concepts in familial Mediterranean fever: is it possible to have an autosomal-recessive disease with only one mutation?
    Ozen S
    Arthritis Rheum; 2009 Jun; 60(6):1575-7. PubMed ID: 19479854
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous necrotizing vasculitis as a manifestation of familial Mediterranean fever.
    Komatsu S; Honma M; Igawa S; Tsuji H; Ishida-Yamamoto A; Migita K; Ida H; Iizuka H
    J Dermatol; 2014 Sep; 41(9):827-9. PubMed ID: 25109905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.